the chemotherapy, when we talk about glioblastoma and then talk also a lot about clinical trial. This is really, we know that really for glioblastoma, the only approved treatment, or the ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

Rare cancers are less known and pose challenges due to limited research and diagnostic difficulties. Environmental factors, ...

Some people use Zollinger-Ellison syndrome and gastrinoma interchangeably. Learn the similarities and differences between the two.

A radiopharmaceutical medicine developed by Germany’s ITM outperformed everolimus, an older chemotherapy ... treatment,” said Schuster, who stepped down Sept. 1. ITM’s study, dubbed Compete, enrolled ...

The combination of chemotherapy and radioembolization appeared safe and effective in patients with well-differentiated, liver-dominant, grade 3 NETs.

Clinicopathological factors related to survival in gastroenteropancreatic neuroendocrine tumors (GEP-NET): 20 years experience in the American British Cowdray Medical Center. This is an ASCO Meeting ...

Molecular and clinical profiling of gastroenteropancreatic (GEP) neuroendocrine tumors (NETs): An analysis of the Oncology Research Information Exchange Network database. This is an ASCO Meeting ...

"Combining TACE with immunotherapy-based treatment can potentially enhance antitumor efficacy by activating the immune system, and therefore converting cold tumor to hot tumor responding to ...

and the potential treatment of SCLC and neuroendocrine tumors. These forward-looking statements may contain words such as “aim,” “anticipate,” “believe,” “could,” “estimate ...

SCLC represents almost 15% of the 2.5 million annual lung cancer diagnoses globally ... who have previously undergone a minimum of one platinum-based chemotherapy regimen. It is being assessed both as ...

and neuroendocrine tumors (NETs), which are neoplasms that arise from cells of the endocrine and nervous systems. Cushing syndrome (CS) is defined by signs and symptoms caused by hypercortisolism.